# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** CHIME syndrome
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **CHIME syndrome**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-01-05T17:34:16.997832

1. ceroni2018largedeletionin pages 1-2
2. wu2020theglycosylphosphatidylinositolbiosynthesis pages 5-7
3. sidpra2024theclinicaland pages 1-1
4. conte2023metaboliccardiomyopathiesand pages 17-19
5. altassan2018hyperphosphatasiawithmental pages 1-2
6. patalan2024inheritedglycosylphosphatidylinositoldeficiency pages 1-3
7. sidpra2024theclinicaland pages 10-11
8. alvarezsanchez2024thegpianchorbiosynthesis pages 2-3
9. alvarezsanchez2024thegpianchorbiosynthesis pages 8-9
10. alvarezsanchez2024thegpianchorbiosynthesis pages 1-2
11. alvarezsanchez2024thegpianchorbiosynthesis pages 9-11
12. alvarezsanchez2024thegpianchorbiosynthesis pages 4-5
13. alvarezsanchez2024thegpianchorbiosynthesis pages 3-4
14. alvarezsanchez2024thegpianchorbiosynthesis pages 7-8
15. alvarezsanchez2024thegpianchorbiosynthesis pages 6-7
16. https://doi.org/10.1093/brain/awae056
17. https://doi.org/10.1007/s00018-024-05284-2
18. https://doi.org/10.1590/1678-4685-gmb-2017-0172
19. https://doi.org/10.1016/j.ymgmr.2018.01.007
20. https://doi.org/10.1186/s13023-020-01401-z
21. https://doi.org/10.5114/polp.2024.146394
22. https://doi.org/10.3390/ijms24108632
23. https://doi.org/10.1093/brain/awae056;
24. https://doi.org/10.1007/s00018-024-05284-2;
25. https://doi.org/10.1590/1678-4685-gmb-2017-0172;
26. https://doi.org/10.1016/j.ymgmr.2018.01.007;
27. https://doi.org/10.1186/s13023-020-01401-z;
28. https://doi.org/10.5114/polp.2024.146394;
29. https://doi.org/10.3390/ijms24108632;
30. https://doi.org/10.1590/1678-4685-gmb-2017-0172,
31. https://doi.org/10.1016/j.ymgmr.2018.01.007,
32. https://doi.org/10.1186/s13023-020-01401-z,
33. https://doi.org/10.3390/ijms24108632,
34. https://doi.org/10.5114/polp.2024.146394,
35. https://doi.org/10.1093/brain/awae056,
36. https://doi.org/10.1007/s00018-024-05284-2,
37. https://doi.org/10.1002/humu.23219,